[{"id":"8a932c0d-6400-4ece-8158-addbdb376cf0","acronym":"","url":"https://clinicaltrials.gov/study/NCT05168566","created_at":"2021-12-23T16:53:43.266Z","updated_at":"2024-07-02T16:35:47.483Z","phase":"Phase 2b","brief_title":"Study to Evaluate Sutetinib Maleate Capsule in Locally Advanced or Metastatic Non-small Cell Lung Cancer","source_id_and_acronym":"NCT05168566","lead_sponsor":"Teligene US","biomarkers":" EGFR","pipe":" | ","alterations":" EGFR mutation • EGFR L861Q • EGFR G719X • EGFR S768I • EGFR G719X + EGFR S768I","tags":["EGFR"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e EGFR mutation • EGFR L861Q • EGFR G719X • EGFR S768I • EGFR G719X + EGFR S768I"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e sutetinib (SZMD4)"],"overall_status":"Recruiting","enrollment":" Enrollment 99","initiation":"Initiation: 09/01/2022","start_date":" 09/01/2022","primary_txt":" Primary completion: 08/01/2024","primary_completion_date":" 08/01/2024","study_txt":" Completion: 02/01/2025","study_completion_date":" 02/01/2025","last_update_posted":"2023-05-22"}]